INTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Movement DisordersTavapadon Treatment for Early Parkinson Disease: Findings from the TEMPO Trials
Hubert Fernandez, MDHubert Fernandez, MD- SEP-OCT 2026 ISSUE
An Update on Devices for Essential Tremor Treatment
Mackenzie R. Paller-Moore, MD; Katelynn Getchell, MDMackenzie R. Paller-Moore, MD; Katelynn Getchell, MD - SEP-OCT 2026 ISSUE
Wearable Devices in Parkinson Disease: A Practical Guide for Clinicians
Siegfried Hirczy, MD; Ruth B. Schneider, MDSiegfried Hirczy, MD; Ruth B. Schneider, MD - SEP-OCT 2026 ISSUE
Freezing of Gait in Parkinson Disease: Technology for Evaluation and Treatment
John B. Sanderson, MDJohn B. Sanderson, MD